Friday - December 4, 2020
AcuityBio and Cook Biotech Announce Agreements for Strategic Collaboration and Development of AcuityBio's ABC103
September 05, 2018
WEST LAFAYETTE, Indiana, Sept. 5 -- Purdue University issued the following news release:

AcuityBio Inc., a developer of novel drug-delivery, combination products, announced Wednesday (Sept. 5) that it has entered into agreements with Cook Biotech Inc., a leader in advanced biomaterials and regenerative medicine.

Under the terms of the agreements, both companies will collaborate in the advancement of AcuityBio's ABC103 lead product for lung cancer, which will utilize Co . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

What's your
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products